Marc Bregman - 17 May 2021 Form 4 Insider Report for ELITE PHARMACEUTICALS INC /NV/ (ELTP)

Role
CFO, Secretary, Treasurer
Signature
Marc Bregman
Issuer symbol
ELTP
Transactions as of
17 May 2021
Transactions value $
$16,860
Form type
4
Filing time
07 Jul 2021, 17:00:33 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTP Options Award $16,860 +300,000 $0.0562 300,000 17 May 2021 Common Stock 300,000 $0.0562 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options were awarded by the Board of Directors as part of Mr. Bregman's employment agreement.
F2 The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on May 17, 2022